NEWS | Appili Therapeutics

News Highlights

Check this page for recent news from Appili Therapeutics.

Members of the media can contact us here, or for general inquiries, contact us here.

May 21, 2020
Health Canada Clears Appili Therapeutics’ Phase 2 Clinical Trial Evaluating Favipiravir as a Prophylactic Agent Against COVID-19 Outbreaks
May 11, 2020
Appili Therapeutics Submits CTA with Health Canada to Sponsor Prophylactic Phase 2 Clinical Trial Evaluating FUJIFILM Toyama Chemical’s Favipiravir as a Preventative Measure Against COVID-19 in Canadian Long-Term Care Facilities
May 4, 2020
Appili Therapeutics to Present at Maxim Group’s Infectious Disease Virtual Conference
April 21, 2020
Appili Therapeutics Names Infectious Disease Specialist Yoav Golan, MD, as its Chief Medical Officer
February 27, 2020
Appili Therapeutics Reports Financial and Operational Results for Third Quarter Fiscal Year 2020 Copy